Bausch Health Companies (BHC) Short term Debt (2009 - 2026)

Bausch Health Companies has disclosed Short term Debt across 17 years of filings, most recently posting $889.0 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $889.0 million, up 215.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $889.0 million (up 215.25% YoY), and the FY2025 annual result was $225.0 million, down 91.59% from the prior year.
• Short term Debt came in at $889.0 million for Q1 2026 at Bausch Health Companies, up from $225.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $2.7 billion in Q4 2024 to a low of $150.0 million in Q2 2022.
• The 5-year median for Short term Debt is $451.0 million (2023), against an average of $615.0 million.
• Across the five-year window, Short term Debt soared 494.22% in 2024 and tumbled 91.59% in 2025, its largest moves.
• Bausch Health Companies' Short term Debt stood at $432.0 million in 2022, then gained by 4.17% to $450.0 million in 2023, then jumped by 494.22% to $2.7 billion in 2024, then sank by 91.59% to $225.0 million in 2025, then soared by 295.11% to $889.0 million in 2026.
• The last three Short term Debt figures came in at $889.0 million (Q1 2026), $225.0 million (Q4 2025), and $579.0 million (Q3 2025), per Business Quant data.